Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 12, Pages 2732
Publisher
MDPI AG
Online
2017-12-19
DOI
10.3390/ijms18122732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis
- (2017) Thaiz Borin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Patient-derived xenografts undergo mouse-specific tumor evolution
- (2017) Uri Ben-David et al. NATURE GENETICS
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- New Directions in Anti-Angiogenic Therapy for Glioblastoma
- (2017) Nancy Wang et al. Neurotherapeutics
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis
- (2017) X W Chen et al. ONCOGENE
- HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model
- (2017) Thaiz F. Borin et al. PLoS One
- Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
- (2017) Kartik Angara et al. Translational Oncology
- Review of cancer treatment with immune checkpoint inhibitors
- (2017) Christiane Thallinger et al. WIENER KLINISCHE WOCHENSCHRIFT
- Advances in Immunotherapy for Glioblastoma Multiforme
- (2017) Boyuan Huang et al. Journal of Immunology Research
- The Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells
- (2017) Alessandra Audia et al. Frontiers in Oncology
- Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models
- (2017) Meenu Jain et al. Scientific Reports
- Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth
- (2017) B. R. Achyut et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment
- (2016) Qods Lahmar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments
- (2016) B. R. Achyut et al. CANCER BIOLOGY & THERAPY
- Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
- (2016) Daniela F. Quail et al. CLINICAL CANCER RESEARCH
- The angiogenic switch leads to a metabolic shift in human glioblastoma
- (2016) Krishna M. Talasila et al. NEURO-ONCOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects
- (2016) Kenneth G. Liu et al. Oncotarget
- 2016 World Health Organization Classification of Central Nervous System Tumors: An Era of Molecular Biology
- (2016) Reid Hoshide et al. World Neurosurgery
- Glioma Stem Cells: Signaling, Microenvironment, and Therapy
- (2016) Brandon D. Liebelt et al. Stem Cells International
- Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
- (2016) Yang Yi et al. Frontiers in Pharmacology
- VEGF and Intraocular Neovascularization: From Discovery to Therapy
- (2016) Napoleone Ferrara Translational Vision Science & Technology
- Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
- (2016) Benjamin H. Hinrichs et al. Acta Neuropathologica Communications
- BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation
- (2015) Bette K. Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks
- (2015) B.R. Achyut et al. CANCER LETTERS
- Treatment results and outcome in elderly patients with glioblastoma multiforme – A retrospective single institution analysis
- (2015) Markus Hoffermann et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Survival Outcomes in Elderly Patients with Glioblastoma
- (2015) D.S. Tsang et al. CLINICAL ONCOLOGY
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- Glioblastoma survival
- (2014) Adelheid Woehrer et al. CURRENT OPINION IN NEUROLOGY
- Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme
- (2014) Adam M Swartz et al. Immunotherapy
- Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials
- (2014) Elham Fakhrejahani et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Glioblastoma: Background, Standard Treatment Paradigms, and Supportive Care Considerations
- (2014) Susan V. Ellor et al. JOURNAL OF LAW MEDICINE & ETHICS
- Peptide vaccines for the treatment of glioblastoma
- (2014) Adam M. Swartz et al. JOURNAL OF NEURO-ONCOLOGY
- Molecularly targeted therapies for recurrent glioblastoma: current and future targets
- (2014) Darryl Lau et al. Neurosurgical Focus
- Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond
- (2014) Kriti Mittal et al. SEMINARS IN ONCOLOGY
- Effects of Tyrosine Kinase Inhibitors and CXCR4 Antagonist on Tumor Growth and Angiogenesis in Rat Glioma Model: MRI and Protein Analysis Study
- (2014) Meser M. Ali et al. Translational Oncology
- Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
- (2014) J. P. Sullivan et al. Cancer Discovery
- Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers
- (2014) Sam Hanash et al. Genome Medicine
- Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
- (2013) Xiang Wang et al. ANNALS OF SURGICAL ONCOLOGY
- Vertebrate animal models of glioma: Understanding the mechanisms and developing new therapies
- (2013) Leon Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Glioblastoma with Oligodendroglioma Component (GBM-O): Molecular Genetic and Clinical Characteristics
- (2013) Christina L. Appin et al. BRAIN PATHOLOGY
- CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
- (2013) J. Xu et al. CANCER RESEARCH
- microRNAs as potential regulators of myeloid-derived suppressor cell expansion
- (2013) Mohamed El-Gazzar Innate Immunity
- Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma
- (2013) Shi-yong Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Using the molecular classification of glioblastoma to inform personalized treatment
- (2013) Adriana Olar et al. JOURNAL OF PATHOLOGY
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
- (2013) Alicia S Chung et al. NATURE MEDICINE
- Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
- (2013) C. Lu-Emerson et al. NEURO-ONCOLOGY
- Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma
- (2013) A. Broniscer et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis
- (2013) E. Dondossola et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- Targeting Angiogenesis and the Tumor Microenvironment
- (2013) Jennifer Samples et al. Surgical Oncology Clinics of North America
- Cancer stem cell contribution to glioblastoma invasiveness
- (2013) Barbara Ortensi et al. Stem Cell Research & Therapy
- Inflammation-Mediated Genetic and Epigenetic Alterations Drive Cancer Development in the Neighboring Epithelium upon Stromal Abrogation of TGF-β Signaling
- (2013) B. R. Achyut et al. PLoS Genetics
- Mechanisms of Glioma-Associated Neovascularization
- (2012) Matthew E. Hardee et al. AMERICAN JOURNAL OF PATHOLOGY
- Interleukins in glioblastoma pathophysiology: implications for therapy
- (2012) YT Yeung et al. BRITISH JOURNAL OF PHARMACOLOGY
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β
- (2012) Matthew E. Hardee et al. CANCER RESEARCH
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
- (2012) Sadhak Sengupta et al. Clinical & Developmental Immunology
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
- (2012) Y. Piao et al. NEURO-ONCOLOGY
- Radiation, Inflammation, and Immune Responses in Cancer
- (2012) Gabriele Multhoff et al. Frontiers in Oncology
- Signal transduction by vascular endothelial growth factor receptors
- (2011) Sina Koch et al. BIOCHEMICAL JOURNAL
- Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
- (2011) D. A. Hume et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment
- (2011) Bhagelu Ram Achyut et al. GASTROENTEROLOGY
- The brain tumor microenvironment
- (2011) Nikki A. Charles et al. GLIA
- Clinical significance of vasculogenic mimicry in human gliomas
- (2011) Xiao-mei Liu et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma
- (2011) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma
- (2011) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- The Cytochrome P450 4A/F-20-Hydroxyeicosatetraenoic Acid System: A Regulator of Endothelial Precursor Cells Derived from Human Umbilical Cord Blood
- (2011) A. M. Guo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
- (2011) C. E. Fadul et al. NEURO-ONCOLOGY
- A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
- (2011) T. N. Kreisl et al. NEURO-ONCOLOGY
- Transdifferentiation of glioblastoma cells into vascular endothelial cells
- (2011) Y. Soda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
- (2011) Pipsa Saharinen et al. TRENDS IN MOLECULAR MEDICINE
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Effects of Sublethal Irradiation on Patterns of Engraftment after Murine Bone Marrow Transplantation
- (2010) Jacob Andrade et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
- (2010) Michael J. Campbell et al. BREAST CANCER RESEARCH AND TREATMENT
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
- (2010) E. G. Van Meir et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of sunitinib malate in patients with recurrent high-grade glioma
- (2010) B. Neyns et al. JOURNAL OF NEURO-ONCOLOGY
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
- (2010) M. Labussiere et al. NEUROLOGY
- Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma
- (2010) Meser M. Ali et al. PLoS One
- Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
- (2010) Ruman Rahman et al. Journal of Oncology
- Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
- (2010) L. Oliver et al. Current Molecular Pharmacology
- Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy
- (2009) S. J. Priceman et al. BLOOD
- Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma
- (2009) David A. Reardon et al. CANCER
- Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice
- (2009) Walid S. Kamoun et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences
- (2009) Marie Brázdová et al. NUCLEIC ACIDS RESEARCH
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
- (2009) F. Shojaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- (2008) K. Movahedi et al. BLOOD
- Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
- (2008) Y. Sawanobori et al. BLOOD
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Pathways connecting inflammation and cancer
- (2008) Paola Allavena et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Emerging antiangiogenic treatments for gliomas – efficacy and safety issues
- (2008) Jörg Dietrich et al. CURRENT OPINION IN NEUROLOGY
- Expression of CYP4A1 in U251 Human Glioma Cell Induces Hyperproliferative Phenotype in Vitro and Rapidly Growing Tumors in Vivo
- (2008) A. M. Guo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started